Akorn Could Alter 'Material Adverse Effect' Law In Delaware
As Law360 reported, Vice Chancellor J. Travis Laster of the Delaware Court of Chancery issued a pathbreaking opinion allowing pharmaceutical company Fresenius Kabi AG to abandon its merger with Akorn Inc....To view the full article, register now.
Already a subscriber? Click here to view full article